Due to the essential role of the transcription factor STAT5 for the survival and proliferation of AML cells with this specific mutation, excessively active STAT5 can lead to drug resistance to FLT3 inhibitor.2, 3. This evidence concerns the gene FLT3 and acute myeloid leukemia.